Nursing, Midwifery and Allied Health Professions Research Unit, Glasgow Caledonian University, Glasgow, UK.
Public Health Department, Health Sciences Faculty, University of Brasilia, Brasilia, Brazil.
Cochrane Database Syst Rev. 2020 Dec 7;12(12):CD003864. doi: 10.1002/14651858.CD003864.pub3.
For people with physical, sensory and cognitive limitations due to stroke, the routine practice of oral health care (OHC) may become a challenge. Evidence-based supported oral care intervention is essential for this patient group.
To compare the effectiveness of OHC interventions with usual care or other treatment options for ensuring oral health in people after a stroke.
We searched the Cochrane Stroke Group and Cochrane Oral Health Group trials registers, CENTRAL, MEDLINE, Embase, and six other databases in February 2019. We scanned reference lists from relevant papers and contacted authors and researchers in the field. We handsearched the reference lists of relevant articles and contacted other researchers. There were no language restrictions.
We included randomised controlled trials (RCTs) that evaluated one or more interventions designed to improve the cleanliness and health of the mouth, tongue and teeth in people with a stroke who received assisted OHC led by healthcare staff. We included trials with a mixed population provided we could extract the stroke-specific data. The primary outcomes were dental plaque or denture plaque. Secondary outcomes included presence of oral disease, presence of related infection and oral opportunistic pathogens related to OHC and pneumonia, stroke survivor and providers' knowledge and attitudes to OHC, and patient satisfaction and quality of life.
Two review authors independently screened abstracts and full-text articles according to prespecified selection criteria, extracted data and assessed the methodological quality using the Cochrane 'Risk of bias' tool. We sought clarification from investigators when required. Where suitable statistical data were available, we combined the selected outcome data in pooled meta-analyses. We used GRADE to assess the quality of evidence for each outcome.
Fifteen RCTs (22 randomised comparisons) involving 3631 participants with data for 1546 people with stroke met the selection criteria. OHC interventions compared with usual care Seven trials (2865 participants, with data for 903 participants with stroke, 1028 healthcare providers, 94 informal carers) investigated OHC interventions compared with usual care. Multi-component OHC interventions showed no evidence of a difference in the mean score (DMS) of dental plaque one month after the intervention was delivered (DMS -0.66, 95% CI -1.40 to 0.09; 2 trials, 83 participants; I = 83%; P = 0.08; very low-quality evidence). Stroke survivors had less plaque on their dentures when staff had access to the multi-component OHC intervention (DMS -1.31, 95% CI -1.96 to -0.66; 1 trial, 38 participants; P < 0.0001; low-quality evidence). There was no evidence of a difference in gingivitis (DMS -0.60, 95% CI -1.66 to 0.45; 2 trials, 83 participants; I = 93%; P = 0.26: very low-quality evidence) or denture-induced stomatitis (DMS -0.33, 95% CI -0.92 to 0.26; 1 trial, 38 participants; P = 0.69; low-quality evidence) among participants receiving the multi-component OHC protocol compared with usual care one month after the intervention. There was no difference in the incidence of pneumonia in participants receiving a multi-component OHC intervention (99 participants; 5 incidents of pneumonia) compared with those receiving usual care (105 participants; 1 incident of pneumonia) (OR 4.17, CI 95% 0.82 to 21.11; 1 trial, 204 participants; P = 0.08; low-quality evidence). OHC training for stroke survivors and healthcare providers significantly improved their OHC knowledge at one month after training (SMD 0.70, 95% CI 0.06 to 1.35; 3 trials, 728 participants; I = 94%; P = 0.03; very low-quality evidence). Pooled data one month after training also showed evidence of a difference between stroke survivor and providers' oral health attitudes (SMD 0.28, 95% CI 0.01 to 0.54; 3 trials, 728 participants; I = 65%; P = 0.06; very low-quality evidence). OHC interventions compared with placebo Three trials (394 participants, with data for 271 participants with stroke) compared an OHC intervention with placebo. There were no data for primary outcomes. There was no evidence of a difference in the incidence of pneumonia in participants receiving an OHC intervention compared with placebo (OR 0.39, CI 95% 0.14 to 1.09; 2 trials, 242 participants; I = 42%; P = 0.07; low-quality evidence). However, decontamination gel reduced the incidence of pneumonia among the intervention group compared with placebo gel group (OR 0.20, 95% CI 0.05 to 0.84; 1 trial, 203 participants; P = 0.028). There was no difference in the incidence of pneumonia in participants treated with povidone-iodine compared with a placebo (OR 0.81, 95% CI 0.18 to 3.51; 1 trial, 39 participants; P = 0.77). One OHC intervention compared with another OHC intervention Twelve trials (372 participants with stroke) compared one OHC intervention with another OHC intervention. There was no difference in dental plaque scores between those participants that received an enhanced multi-component OHC intervention compared with conventional OHC interventions at three months (MD -0.04, 95% CI -0.33 to 0.25; 1 trial, 61 participants; P = 0.78; low-quality evidence). There were no data for denture plaque.
AUTHORS' CONCLUSIONS: We found low- to very low-quality evidence suggesting that OHC interventions can improve the cleanliness of patient's dentures and stroke survivor and providers' knowledge and attitudes. There is limited low-quality evidence that selective decontamination gel may be more beneficial than placebo at reducing the incidence of pneumonia. Improvements in the cleanliness of a patient's own teeth was limited. We judged the quality of the evidence included within meta-analyses to be low or very low quality, and this limits our confidence in the results. We still lack high-quality evidence of the optimal approach to providing OHC to people after stroke.
对于因中风而存在身体、感官和认知障碍的患者来说,日常口腔卫生保健(OHC)的实施可能会成为一项挑战。为该患者群体提供循证支持的口腔护理干预措施至关重要。
比较 OHC 干预措施与常规护理或其他治疗方案在确保中风后患者口腔健康方面的效果。
我们检索了 Cochrane 卒中组和 Cochrane 口腔健康组的试验注册库、Cochrane 图书馆、MEDLINE、Embase 以及 2019 年 2 月的另外 6 个数据库。我们对相关论文的参考文献进行了扫描,并联系了该领域的作者和研究人员。我们对相关文章的参考文献进行了手工检索,并联系了其他研究人员。本研究无语言限制。
我们纳入了随机对照试验(RCT),这些试验评估了旨在改善接受医护人员辅助 OHC 的中风患者口腔、舌头和牙齿清洁度和健康状况的一种或多种干预措施。我们纳入了混合人群的试验,但前提是我们可以提取出特定于中风的数据。主要结局是牙菌斑或义齿菌斑。次要结局包括口腔疾病的存在、相关感染的存在以及与 OHC 和肺炎相关的口腔机会性病原体、中风幸存者和提供者对 OHC 的知识和态度、患者满意度和生活质量。
两名综述作者根据预先确定的选择标准独立筛选摘要和全文文章,提取数据,并使用 Cochrane“偏倚风险”工具评估方法学质量。当需要时,我们向研究人员寻求澄清。如果有合适的统计数据,我们将选定的结局数据合并到汇总的 meta 分析中。我们使用 GRADE 评估每个结局的证据质量。
15 项 RCT(22 个随机对照比较)纳入了 3631 名参与者,其中 1546 名参与者患有中风,1028 名医疗保健提供者和 94 名非正式照顾者参与了研究。7 项试验(2865 名参与者,903 名参与者患有中风,83 名医疗保健提供者,1028 名非正式照顾者)比较了 OHC 干预措施与常规护理。多组分 OHC 干预措施在干预 1 个月后,在牙齿菌斑的平均得分(DMS)方面没有证据表明有差异(DMS -0.66,95%CI -1.40 至 0.09;2 项试验,83 名参与者;I = 83%;P = 0.08;非常低质量证据)。当工作人员可以使用多组分 OHC 干预措施时,中风幸存者的义齿上菌斑较少(DMS -1.31,95%CI -1.96 至 -0.66;1 项试验,38 名参与者;P < 0.0001;低质量证据)。参与者在接受多组分 OHC 方案 1 个月后,接受多组分 OHC 方案的参与者在牙龈炎(DMS -0.60,95%CI -1.66 至 0.45;2 项试验,83 名参与者;I = 93%;P = 0.26;非常低质量证据)或义齿诱导性口炎(DMS -0.33,95%CI -0.92 至 0.26;1 项试验,38 名参与者;P = 0.69;低质量证据)方面没有差异。与接受常规护理的参与者相比,接受多组分 OHC 干预的参与者中肺炎的发生率没有差异(99 名参与者;5 例肺炎)(99 名参与者;5 例肺炎)(99 名参与者;5 例肺炎)(99 名参与者;5 例肺炎)(OR 4.17,CI 95% 0.82 至 21.11;1 项试验,204 名参与者;P = 0.08;低质量证据)。对中风幸存者和医疗保健提供者进行的 OHC 培训在培训 1 个月后显著提高了他们的 OHC 知识(SMD 0.70,95%CI 0.06 至 1.35;3 项试验,728 名参与者;I = 94%;P = 0.03;非常低质量证据)。培训 1 个月后汇总的数据还表明,中风幸存者和提供者的口腔健康态度存在差异(SMD 0.28,95%CI 0.01 至 0.54;3 项试验,728 名参与者;I = 65%;P = 0.06;非常低质量证据)。OHC 干预与安慰剂 3 项试验(394 名参与者,271 名参与者患有中风)比较了 OHC 干预与安慰剂。没有主要结局的数据。与安慰剂相比,接受 OHC 干预的参与者中肺炎的发生率没有差异(OR 0.39,CI 95% 0.14 至 1.09;2 项试验,242 名参与者;I = 42%;P = 0.07;低质量证据)。然而,与安慰剂凝胶相比,去污凝胶降低了干预组中肺炎的发生率(OR 0.20,CI 95% 0.05 至 0.84;1 项试验,203 名参与者;P = 0.028)。与安慰剂相比,参与者接受聚维酮碘治疗的肺炎发生率没有差异(OR 0.81,CI 95% 0.18 至 3.51;1 项试验,39 名参与者;P = 0.77)。一种 OHC 干预与另一种 OHC 干预 12 项试验(372 名中风参与者)比较了一种 OHC 干预与另一种 OHC 干预。在接受增强型多组分 OHC 干预的参与者与接受常规 OHC 干预的参与者中,在 3 个月时,牙齿菌斑评分没有差异(MD -0.04,95%CI -0.33 至 0.25;1 项试验,61 名参与者;P = 0.78;低质量证据)。没有关于义齿菌斑的数据。
我们发现低质量到非常低质量的证据表明,OHC 干预措施可以改善患者义齿的清洁度以及中风幸存者和提供者的知识和态度。有限的低质量证据表明,选择性去污凝胶可能比安慰剂更能降低肺炎的发病率。患者自身牙齿的清洁度改善有限。我们纳入的 meta 分析中的证据质量被评为低或非常低质量,这限制了我们对结果的信心。我们仍然缺乏关于为中风后患者提供 OHC 的最佳方法的高质量证据。